Vadim Tarasov, Director of the Institute for Translational Medicine and Biotechnology, told Sputnik that the clinical trials on the world’s first coronavirus vaccine at Sechenov’s First State Medical University were successfully completed and the first group of volunteers was discharged on Wednesday and the second will be on July 20.
On June 18, Russia’s Institute of Epidemiology and Microbiology began clinical trials of the vaccine.
“Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus,” Tarasov said.
The aim of this stage of the study was to demonstrate the vaccine safety in human health, which was successfully carried out according to Alexander Lukashev, director of the Institute of Medical Parasitology, Tropicals and Vector-Bored Disease at Sechenov University.
“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik.
The developer ‘s strategy, including the uncertainty of the epidemiological situation and the option of increasing growth, has already decided the future development plan for the vaccine, Lukashev added.
“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research center that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway,” Tarasov noted. (Sputnik/ ANI)
Erick Miser is a Senior Author of Read Us 24×7. He lives in the United States of America. He’s best known for Technical, business, and review Content Writing along with the proper knowledge base of SEO.